STRS Ohio’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-44,242
Closed -$8.13M 2380
2021
Q2
$8.13M Buy
44,242
+6,440
+17% +$1.18M 0.03% 433
2021
Q1
$5.78M Sell
37,802
-133,905
-78% -$20.5M 0.02% 473
2020
Q4
$26.8M Sell
171,707
-75,916
-31% -$11.9M 0.1% 236
2020
Q3
$28.3M Sell
247,623
-49,276
-17% -$5.64M 0.12% 195
2020
Q2
$33.3M Sell
296,899
-71,142
-19% -$7.98M 0.15% 165
2020
Q1
$33M Sell
368,041
-100,536
-21% -$9.03M 0.17% 137
2019
Q4
$50.7M Sell
468,577
-165,672
-26% -$17.9M 0.21% 119
2019
Q3
$62.1M Sell
634,249
-2,520
-0.4% -$247K 0.27% 90
2019
Q2
$83.4M Sell
636,769
-2,959
-0.5% -$388K 0.37% 62
2019
Q1
$86.5M Buy
639,728
+32,111
+5% +$4.34M 0.39% 59
2018
Q4
$59.2M Buy
607,617
+10,792
+2% +$1.05M 0.3% 82
2018
Q3
$83M Sell
596,825
-38,629
-6% -$5.37M 0.36% 59
2018
Q2
$78.9M Buy
635,454
+61,971
+11% +$7.69M 0.34% 71
2018
Q1
$63.9M Buy
573,483
+9,713
+2% +$1.08M 0.28% 105
2017
Q4
$67.4M Buy
563,770
+5,832
+1% +$697K 0.29% 100
2017
Q3
$78.3M Buy
557,938
+24,756
+5% +$3.47M 0.34% 75
2017
Q2
$64.9M Sell
533,182
-3,230
-0.6% -$393K 0.29% 96
2017
Q1
$65M Sell
536,412
-68,241
-11% -$8.27M 0.28% 96
2016
Q4
$74M Sell
604,653
-7,265
-1% -$889K 0.33% 79
2016
Q3
$75M Buy
611,918
+51,809
+9% +$6.35M 0.34% 71
2016
Q2
$65.4M Buy
560,109
+52,710
+10% +$6.15M 0.29% 97
2016
Q1
$70.6M Sell
507,399
-17,215
-3% -$2.4M 0.32% 81
2015
Q4
$100M Buy
524,614
+105
+0% +$20K 0.45% 50
2015
Q3
$82M Sell
524,509
-39,680
-7% -$6.21M 0.39% 58
2015
Q2
$102M Sell
564,189
-16,042
-3% -$2.9M 0.45% 45
2015
Q1
$101M Buy
580,231
+102,003
+21% +$17.7M 0.44% 48
2014
Q4
$88.5M Sell
478,228
-83,526
-15% -$15.5M 0.38% 63
2014
Q3
$93.2M Sell
561,754
-90,000
-14% -$14.9M 0.41% 60
2014
Q2
$102M Buy
651,754
+182,436
+39% +$28.5M 0.45% 50
2014
Q1
$71.4M Buy
469,318
+75,000
+19% +$11.4M 0.32% 83
2013
Q4
$52.5M Buy
394,318
+76,800
+24% +$10.2M 0.24% 127
2013
Q3
$36.9M Buy
317,518
+264,078
+494% +$30.7M 0.16% 178
2013
Q2
$4.93M Buy
+53,440
New +$4.93M 0.02% 494